1
|
Bakshi G, Tongaonkar H, Addla S, Menon S, Pradhan A, Kumar A, Bapat A, Gore A, Joshi A, Raja A, Bradoo A, Ramesh A, Kumar A, Agrawal A, Ambekar A, Joshi A, Singh A, Singh BP, Dabkara D, Khadakban D, Gautam G, Prakash G, Pahwa HS, Goel HK, Kulkarni J, Mishra JJ, Patel K, Pal M, Chibber PJ, Tiwari P, Naik R, Raghunath SK, Krishnatry R, Shimpi R, Sharma R, Taran R, Trivedi S, Nabar S, Surekha S, Kumar S, Sawaimoon SK, Raina S, Narasimha S, Advani S, Ghouse SM, Muddu VK, Maniar V, Venkat V, Murthy V. Expert survey on management of prostate cancer in India: Real-world insights into practice patterns. Indian J Cancer 2022; 59:S19-S45. [PMID: 35343189 DOI: 10.4103/ijc.ijc_1145_21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
To gain insights on the diverse practice patterns and treatment pathways for prostate cancer (PC) in India, the Urological Cancer Foundation convened the first Indian survey to discuss all aspects of PC, with the objective of guiding clinicians on optimizing management in PC. A modified Delphi method was used, wherein a multidisciplinary panel of oncologists treating PC across India developed a questionnaire related to screening, diagnosis and management of early, locally advanced and metastatic PC and participated in a web-based survey (WBS) (n = 62). An expert committee meeting (CM) (n = 48, subset from WBS) reviewed the ambiguous questions for better comprehension and reanalyzed the evidence to establish a revote for specific questions. The threshold for strong agreement and agreement was ≥90% and ≥75% agreement, respectively. Sixty-two questions were answered in the WBS; in the CM 31 questions were revoted and 4 questions were added. The panelists selected answers based on their best opinion and closest to their practice strategy, not considering financial constraints and access challenges. Of the 66 questions, strong agreement was reached for 17 questions and agreement was achieved for 22 questions. There were heterogeneous responses for 27 questions indicative of variegated management approaches. This is one of the first Indian survey, documenting the diverse clinical practice patterns in the management of PC in India. It aims to provide guidance in the face of technological advances, resource constraints and sparse high-level evidence.
Collapse
Affiliation(s)
- Ganesh Bakshi
- Department of Uro-Oncology, P D Hinduja National Hospital, Mumbai, India
| | - Hemant Tongaonkar
- Director of Surgical Oncology and Uro-Oncology, Max Nanavati Hospital, Mumbai, India
| | - Sanjai Addla
- Department of Uro-Oncology, Apollo Hospital, Hyderabad, India
| | - Santosh Menon
- Department of Uro-Onco Pathology, Tata Memorial Hospital & HBNI, Mumbai, India
| | - Aditya Pradhan
- Department of Uro-Oncology, BL Kapoor Hospital, Delhi, India
| | - Abhay Kumar
- Department of Uro-Oncology, Narayana Health, Kolkata, India
| | - Abhijit Bapat
- Department of Urology, Bapat Urology Hospital, Mumbai, India
| | - Adwaita Gore
- Department of Medical Oncology, Prince Aly Khan Hospital, Mumbai, India
| | - Amit Joshi
- Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India
| | - Anand Raja
- Department of Uro-Oncology, Cancer Institute (WIA), Adyar, Chennai, India
| | - Anil Bradoo
- Department of Urology, Excel Urology Centre, Mumbai, India
| | - Anita Ramesh
- Department of Medical Oncology, Apollo Hospital, Chennai, India
| | - Anup Kumar
- Department of Urology, Safdarjung Hospital, Delhi, India
| | - Archi Agrawal
- Department of Nuclear Medicine, Tata Memorial Hospital & HBNI, Mumbai, India
| | | | - Ashish Joshi
- Department of Medical Oncology, Mumbai Oncocare Centre, Mumbai, India
| | - Ashish Singh
- Department of Medical Oncology, Christian Medical College, Vellore, India
| | | | - Deepak Dabkara
- Department of Medical Oncology, Tata Memorial Centre, Kolkata, India
| | - Dhiraj Khadakban
- Department of Surgical Oncology, Oncolife Hospital, Satara, India
| | - Gagan Gautam
- Department of Uro-Oncology, Max Healthcare, Delhi, India
| | - Gagan Prakash
- Department of Uro-Oncology, Tata Memorial Hospital & HBNI, Mumbai, India
| | | | | | | | | | - Kaushal Patel
- Department of Medical Oncology, Tristar Hospital, Surat, India
| | - Mahendra Pal
- Department of Uro-Oncology, Tata Memorial Hospital & HBNI, Mumbai, India
| | | | - Priya Tiwari
- Department of Medical Oncology, Artemis Hospital, Delhi, India
| | - Radheshyam Naik
- Department of Medical Oncology, HCG Hospital, Bangalore, India
| | - S K Raghunath
- Department of Uro-Oncology, HCG Hospital, Bangalore, India
| | - Rahul Krishnatry
- Department of Radiation Oncology, Tata Memorial Hospital & HBNI, Mumbai, India
| | | | - Rakesh Sharma
- Department of Uro-Oncology, Indo-American Hospital, Hyderabad, India
| | - Rakesh Taran
- Department of Medical Oncology, CHL Hospital, Indore, India
| | - Sameer Trivedi
- Department of Urology, Institute of Medical Science, Varanasi, India
| | - Sanjay Nabar
- Department of Urology, Nanavati Hospital, Mumbai, India
| | | | - Satish Kumar
- Department of Surgical Oncology, Mohan's Medicity Hospital, Madurai, India
| | | | | | | | - Suresh Advani
- Department of Medical Oncology, SL Raheja Hospital, Mumbai, India
| | | | | | - Vashishth Maniar
- Department of Medical Oncology, Mumbai Oncocare Centre, Mumbai, India
| | - Vivek Venkat
- Department of Urology, Nanavati Hospital, Mumbai, India
| | - Vedang Murthy
- Department of Radiation Oncology, Tata Memorial Hospital & HBNI, Mumbai, India
| |
Collapse
|